Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SSP-004184AQ versus Exjade for transfusional iron overload in beta-thalassemia
2013-000743-33Phase 2Completed
- Sponsor
- Takeda
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in transfusional hemosiderosis and beta thalassemia comparing SSP-004184AQ arm with Exjade arm (2 arms). Primary endpoint: Change from baseline in liver iron concentration at Week 48. Started Oct 2013; status: completed.
02
Drugs
deferitazoledeferasirox
03
Conditions
transfusional hemosiderosisbeta thalassemia
Beyond the preview
Go deeper on 2013-000743-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000743-33.